Omnimmune Holdings, Inc. Stock Other OTC
Equities
OMMH
US68216A1043
Biotechnology & Medical Research
Financials (USD)
Sales 2008 | - | Sales 2009 | - | Capitalization | 1.43M |
---|---|---|---|---|---|
Net income 2008 | -5M | Net income 2009 | -1M | EV / Sales 2008 | - |
Net Debt 2008 | 2.3M | Net Debt 2009 | 2.58M | EV / Sales 2009 | - |
P/E ratio 2008 |
-0.55
x | P/E ratio 2009 |
-0.8
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 42.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | - |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |